Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Cardiology

Understanding Your Diagnosis: Fast Rhythms and Slow Signals

At a Glance

Hereditary atrial tachyarrhythmia-infra-Hisian cardiac conduction disease causes fast or irregular rhythms in the atria and slow or blocked electrical signals below the Bundle of His. Genetic testing identifies the variant, while ongoing ECG and rhythm monitoring help track changes and guide care.

It is completely normal to feel overwhelmed or anxious after receiving a diagnosis with a name as long and complex as Hereditary atrial tachyarrhythmia-infra-Hisian cardiac conduction disease. Learning that you have a rare, genetic heart condition can be intimidating [1]. However, this diagnosis is actually a descriptive map that helps your doctors understand exactly which parts of your heart’s electrical system need attention.

By breaking down the name, we can understand the two main “electrical” problems occurring at once:

  • Hereditary: This means the condition is passed down through families via your DNA, typically due to a pathogenic variant.
  • Atrial tachyarrhythmia: “Atrial” refers to the top chambers of your heart (the atria). “Tachyarrhythmia” means a fast or irregular heart rhythm, such as atrial fibrillation (AFib) or atrial flutter [2].
  • Infra-Hisian: This describes the specific location of the problem. It occurs “below” (infra) a bundle of fibers called the Bundle of His, which is the main highway for electrical signals traveling to the bottom chambers of your heart [3].
  • Cardiac conduction disease: This means the electrical signals are moving too slowly, or are sometimes blocked entirely, as they try to reach the bottom of the heart to trigger a beat [3].

The Fast and Slow Interaction

In a healthy heart, electricity flows in a smooth, timed sequence from top to bottom. In your condition, the heart faces two conflicting challenges at the same time: the top chambers may race or quiver (fast), while the “wiring” in the lower section conducts signals too slowly (slow) [4].

These two problems are often different sides of the same coin. The pathogenic variant that makes the top of the heart prone to “short-circuiting” into a fast rhythm can also cause the lower wiring to conduct poorly [3][4]. This is why your care team must carefully balance your treatments—some medications that slow down a racing heart could dangerously worsen a slow-conducting signal in the lower chambers.

The Role of Your Genes

This condition is considered genetically heterogeneous, which is medical shorthand for saying that different pathogenic variants can lead to overlapping heart symptoms [3]. Identifying your specific gene is key to predicting how the disease might act:

  • SCN5A: This gene provides instructions for “sodium channels” that control the flow of electricity in heart cells [5]. Depending on the variant, it can lead to AFib, progressive conduction block, and overlap with conditions like Brugada syndrome [4].
  • PRKAG2: This gene is related to how the heart uses energy. Variants here cause a distinct syndrome that often includes a thickened heart muscle (hypertrophic cardiomyopathy), glycogen storage issues, and conduction blocks [6][7].
  • LMNA: Pathogenic variants in this gene can be more aggressive, often involving the heart’s physical structure as well as its electricity, leading to dilated cardiomyopathy (a weakened heart muscle) over time [8][9].
    (Note: Only variants classified as “pathogenic” or “likely pathogenic” guide cascade testing; a “Variant of Uncertain Significance” (VUS) requires further clinical evaluation.)

Age of Onset and Progression

One of the most challenging aspects of this diagnosis is its variable penetrance. This means that even people in the same family with the exact same genetic variant may have very different experiences [6]. Some people may show signs on an ECG in childhood, while others may not develop symptoms until their 30s, 40s, or even later [10][11].

The disease may be progressive, meaning the electrical “wiring” can conduct more slowly as the years go by [3]. For many, the first sign is a fast rhythm like AFib or an “accidental” finding on a routine ECG [2]. Over time, as the infra-Hisian block becomes more pronounced, the heart may struggle to maintain a safe, steady beat, which is why your doctors will monitor you closely for years to come [3][12]. Because the “infra-Hisian” area is deep in the heart’s wiring, a standard ECG may sometimes look normal even when the disease is present, leading some doctors to use more advanced tests to check the speed of your heart’s signals [13].

Common questions in this guide

What does hereditary atrial tachyarrhythmia-infra-Hisian cardiac conduction disease mean?
It is an inherited heart rhythm condition with two linked features: the atria may beat too fast or irregularly, while electrical signals below the Bundle of His move too slowly or become blocked. This combination can affect which medicines and monitoring approaches are safest.
Why can a genetic heart condition cause both a fast rhythm and heart block?
A pathogenic variant can affect electrical activity in both the upper chambers and the lower conduction system. That can make the atria prone to rhythms such as atrial fibrillation or flutter while slowing signals that should reach the lower chambers.
Which genes may be involved in this condition?
Examples include SCN5A, PRKAG2, and LMNA, but different variants can produce overlapping features. SCN5A may affect sodium-channel signaling, PRKAG2 may be linked with a thickened heart muscle and conduction block, and LMNA may be associated with later weakening of the heart muscle.
Can this inherited conduction disease get worse over time?
It can be progressive, meaning the heart’s electrical signals may conduct more slowly as the years pass. People with the same variant may show changes at different ages, so clinicians may use repeated ECGs, longer-term monitoring, or more advanced signal tests.
Should my relatives have genetic testing or heart screening?
Ask your cardiology and genetics teams whether children, siblings, or other blood relatives need screening and when it should begin. Cascade testing is generally guided by a pathogenic or likely pathogenic variant; a variant of uncertain significance does not by itself establish the diagnosis and needs clinical evaluation.
How are fast heart rhythms treated when conduction is already slow?
Medicines that slow a racing heart can also worsen an already slow or blocked signal, so treatment must be individualized. Your care team may balance rhythm treatment with ECG and longer-term monitoring rather than assuming one medicine is safe for everyone.

Get notified when new evidence is published on Hereditary atrial tachyarrhythmia-infra-Hisian cardiac conduction disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (13)
  1. 1

    Molecular and genetic insights into progressive cardiac conduction disease.

    Asatryan B, Medeiros-Domingo A

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2019; (21(8)):1145-1158 doi:10.1093/europace/euz109.

    PMID: 31087102
  2. 2

    aTrial arrhythmias in inhEriTed aRrhythmIa Syndromes: results from the TETRIS study.

    Conte G, Bergonti M, Probst V, et al.

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2024; (26(12)) doi:10.1093/europace/euae288.

    PMID: 39527076
  3. 3

    Current Topics of Progressive Cardiac Conduction Disease.

    Sumitomo N, Mori H, Kumamoto T, et al.

    Journal of arrhythmia 2026; (42(3)):e70383 doi:10.1002/joa3.70383.

    PMID: 42368294
  4. 4

    Biophysical mechanisms of myocardium sodium channelopathies.

    Zaytseva AK, Kulichik OE, Kostareva AA, Zhorov BS

    Pflugers Archiv : European journal of physiology 2024; (476(5)):735-753 doi:10.1007/s00424-024-02930-3.

    PMID: 38424322
  5. 5

    Cardiac Arrhythmias Related to Sodium Channel Dysfunction.

    Savio-Galimberti E, Argenziano M, Antzelevitch C

    Handbook of experimental pharmacology 2018; (246()):331-354 doi:10.1007/164_2017_43.

    PMID: 28965168
  6. 6

    Identification, clinical manifestation and structural mechanisms of mutations in AMPK associated cardiac glycogen storage disease.

    Hu D, Hu D, Liu L, et al.

    EBioMedicine 2020; (54()):102723 doi:10.1016/j.ebiom.2020.102723.

    PMID: 32259713
  7. 7

    Human γ2-AMPK Mutations.

    Yavari A, Sarma D, Sternick EB

    Methods in molecular biology (Clifton, N.J.) 2018; (1732()):581-619 doi:10.1007/978-1-4939-7598-3_37.

    PMID: 29480501
  8. 8

    Gene-Based Risk Stratification for Cardiac Disorders in LMNA Mutation Carriers.

    Nishiuchi S, Makiyama T, Aiba T, et al.

    Circulation. Cardiovascular genetics 2017; (10(6)) doi:10.1161/CIRCGENETICS.116.001603.

    PMID: 29237675
  9. 9

    LMNA Deficiency Reveals a Role for SK3 Channel Dysfunction in Atrioventricular Block.

    Li T, Wang X, Song J, et al.

    JACC. Clinical electrophysiology 2026; doi:10.1016/j.jacep.2026.06.035.

    PMID: 42569976
  10. 10

    SCN5A mutations in 442 neonates and children: genotype-phenotype correlation and identification of higher-risk subgroups.

    Baruteau AE, Kyndt F, Behr ER, et al.

    European heart journal 2018; (39(31)):2879-2887 doi:10.1093/eurheartj/ehy412.

    PMID: 30059973
  11. 11

    Phenotypic expression of rare progressive cardiac conduction disease variants in the general population.

    Shah RA, Ramírez J, Kirkby C, et al.

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2025; (27(6)) doi:10.1093/europace/euaf103.

    PMID: 40359255
  12. 12

    Genotype-phenotype relationship and risk stratification in loss-of-function SCN5A mutation carriers.

    Robyns T, Nuyens D, Vandenberk B, et al.

    Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 2018; (23(5)):e12548 doi:10.1111/anec.12548.

    PMID: 29709101
  13. 13

    A reassuring ECG is not enough in myotonic dystrophy type 1: A systematic review and meta-analysis.

    Shatarat F, Bdarnh O, Alomari AA, et al.

    Indian pacing and electrophysiology journal 2026; doi:10.1016/j.ipej.2026.09.012.

    PMID: 42822762

This page explains the genetic and electrical features of hereditary atrial tachyarrhythmia-infra-Hisian cardiac conduction disease for education; it does not replace medical advice. Ask your cardiologist and genetics team to interpret your results and monitoring plan.